← Open Payments lookup

DAVID MEDINA: Open Payments

NPI 1588805824 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$69,791 in 308 payments from 24 companies in 2025. Trend: 2023 $32,872 · 2024 $10,263 · 2025 $69,791

Speaker / faculty: $47,204Consulting: $8,550Food & beverage: $8,144Travel & lodging: $5,748Education: $145
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.103$48,972
Otsuka America Pharmaceutical, Inc.22$15,248
Axsome Therapeutics, Inc.25$1,054
E.R. Squibb & Sons, L.L.C.21$744
Teva Pharmaceuticals USA, Inc.22$648
ABBVIE INC.17$498
Alkermes, Inc.25$490
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)12$450
Vanda Pharmaceuticals Inc.13$336
Janssen Pharmaceuticals, Inc8$299

Products named: INGREZZA, REXULTI, Auvelity, COBENFY, AUSTEDO XR, CAPLYTA, VRAYLAR, ARISTADA.

Industry payments across FL — which companies pay providers there.